Ubiquiti Inc. logo

Ubiquiti Inc. (UI)

Market Open
20 Jul, 16:30
NYSE NYSE
$
540. 31
-5.64
-1.0331%
$
33.35B Market Cap
20.49 P/E Ratio
3.2% Div Yield
29,242 Volume
6.87 Eps
$ 545.95
Previous Close
Add Transaction
Day Range
538.45 551.49
Year Range
380 1,099.99
Want to track UI and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Ubiquiti Inc. (UI) Tops Q2 Earnings and Revenue Estimates

Ubiquiti Inc. (UI) Tops Q2 Earnings and Revenue Estimates

Ubiquiti Inc. (UI) came out with quarterly earnings of $2.28 per share, beating the Zacks Consensus Estimate of $1.71 per share. This compares to earnings of $1.38 per share a year ago.

Zacks | 1 year ago
Ubiquiti (UI) Upgraded to Strong Buy: Here's What You Should Know

Ubiquiti (UI) Upgraded to Strong Buy: Here's What You Should Know

Ubiquiti (UI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Zacks | 1 year ago
UI Surges 215% in the Past Year: Should You Bet on the Stock Now?

UI Surges 215% in the Past Year: Should You Bet on the Stock Now?

With healthy fundamentals, UI more than doubled in the past year, making it a solid investment option at the moment.

Zacks | 1 year ago
Ubiquiti (UI) Soars 8.6%: Is Further Upside Left in the Stock?

Ubiquiti (UI) Soars 8.6%: Is Further Upside Left in the Stock?

Ubiquiti (UI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Zacks | 1 year ago
UI Stock Appears a Solid Investment Bet Now: Here's Why

UI Stock Appears a Solid Investment Bet Now: Here's Why

With healthy fundamentals and a unique business model, UI appears to be a solid investment option at the moment.

Zacks | 1 year ago
Undercovered Dozen: Ubiquiti, Ready Capital, Cardiff Oncology, Vodafone +

Undercovered Dozen: Ubiquiti, Ready Capital, Cardiff Oncology, Vodafone +

The 'Undercovered' Dozen series highlights lesser-covered stocks, offering fresh investment ideas and sparking community discussions on their potential. Ubiquiti Inc. shows promise with operational improvements, Ready Capital Corporation faces liquidity risks, and TORM plc is crucial despite energy sector volatility. Esperion Therapeutics' breakout and Cardiff Oncology's promising trial data present compelling buy opportunities, while Advantest Corporation's high valuation suggests caution.

Seekingalpha | 1 year ago
Ubiquiti Is Having Its Tim Cook Moment

Ubiquiti Is Having Its Tim Cook Moment

For several years, starting with COVID, operating miscues by Ubiquiti led to chronic inventory mismanagement, with severe product shortages and a massive increase in inventory. Logistical challenges increased costs and impacted margins, increased financial leverage, and limited Ubiquiti's financial flexibility. Over the last year, Ubiquiti increased its addressable market and executed operationally better than at any time in its history.

Seekingalpha | 1 year ago
Here's Why Ubiquiti Stock is a Solid Investment Bet Now

Here's Why Ubiquiti Stock is a Solid Investment Bet Now

With healthy fundamentals, UI appears to be a solid investment option at the moment.

Zacks | 1 year ago
Ubiquiti Q1 Earnings Beat Estimates on Solid Revenue Growth

Ubiquiti Q1 Earnings Beat Estimates on Solid Revenue Growth

UI reports solid top-line growth year over year in the first quarter of fiscal 2025, backed by healthy traction in North America, Europe, The Middle East and Africa.

Zacks | 1 year ago
Ubiquiti Inc. (UI) Surpasses Q1 Earnings and Revenue Estimates

Ubiquiti Inc. (UI) Surpasses Q1 Earnings and Revenue Estimates

Ubiquiti Inc. (UI) came out with quarterly earnings of $2.14 per share, beating the Zacks Consensus Estimate of $1.77 per share. This compares to earnings of $1.47 per share a year ago.

Zacks | 1 year ago
All You Need to Know About Ubiquiti (UI) Rating Upgrade to Strong Buy

All You Need to Know About Ubiquiti (UI) Rating Upgrade to Strong Buy

Ubiquiti (UI) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks | 1 year ago
The Zacks Analyst Blog Ubiquiti, Spotify, DocuSign, Vertiv and Universal Health

The Zacks Analyst Blog Ubiquiti, Spotify, DocuSign, Vertiv and Universal Health

Ubiquiti, Spotify, DocuSign, Vertiv and Universal Health are included in this Analyst Blog.

Zacks | 1 year ago
Loading...
Load More